Sort by
Refine Your Search
-
. This is a joint post between the Faculties of Medicine and Engineering at the University of Southampton. The post holder will be hybrid and based at both the School of Primary Care, Population Sciences and
-
. Their interdisciplinary research program is dedicated to the use of protein engineering to develop novel antibody-based therapeutics that has led to several therapeutics that are currently approved for clinical use or in
-
learning experience and/or equivalent industry experience in digital pattern cutting and garment technology processes, using industry standard software is also essential. What we can offer you We offer some
-
of successfully planning and progressing work activities is essential. You will have skill level equivalent to achievement of HND, Degree, NVQ4 or basic professional qualification in engineering / Silicon Photonics
-
information about this position in advance of submitting your application. Equality, diversity and inclusion are central to the ethos in the School of Engineering. We give full consideration to applicants who
-
Imagine a resilient built environment; designed to be able to withstand climate impacts – and how to work to create them About us The School of Engineering is one of the UK’s largest with 2700
-
Join the project shaping the future of inclusive technology At the University of Southampton, our research addresses some of the most pressing challenges of today’s world. Now, funded by EPSRC, we
-
researchers from Edge Computing, Detection and Estimation, AI/ML, and Neuromorphic Engineering, to work with us on achieving Edgy Organism project’s ambitious objectives. You will be required to undergo
-
educational objectives; Awareness of how technology enhances online learning experiences; Strong interpersonal skills with a proven ability to quickly establish trust and rapport with on-camera talent from all
-
approaches to understand fundamental biological processes, with the goal of using this information to generate engineered antibodies for use as therapeutics in cancer and autoimmune disease. The appointee is